Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma

BACKGROUND & AIMS: SORAMIC is a prospective phase II randomised controlled trial in hepatocellular carcinoma (HCC). It consists of 3 parts: a diagnostic study and 2 therapeutic studies with either curative ablation or palliative Yttrium-90 radioembolisation combined with sorafenib. We report the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JHEP Rep
Autors principals: Ricke, Jens, Steffen, Ingo G., Bargellini, Irene, Berg, Thomas, Bilbao Jaureguizar, José Ignacio, Gebauer, Bernhard, Iezzi, Roberto, Loewe, Christian, Karçaaltincaba, Musturay, Pech, Maciej, Sengel, Christian, van Delden, Otto, Vandecaveye, Vincent, Zech, Christoph J., Seidensticker, Max
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7578758/
https://ncbi.nlm.nih.gov/pubmed/33103093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2020.100173
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars